These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Recent advances in the study of Ca2+/CaM-activated phosphodiesterases: expression and physiological functions. Zhao AZ; Yan C; Sonnenburg WK; Beavo JA Adv Second Messenger Phosphoprotein Res; 1997; 31():237-51. PubMed ID: 9344255 [No Abstract] [Full Text] [Related]
7. The Rv0805 gene from Mycobacterium tuberculosis encodes a 3',5'-cyclic nucleotide phosphodiesterase: biochemical and mutational analysis. Shenoy AR; Sreenath N; Podobnik M; Kovacevic M; Visweswariah SS Biochemistry; 2005 Dec; 44(48):15695-704. PubMed ID: 16313172 [TBL] [Abstract][Full Text] [Related]
8. Structural and Biochemical Insight into the Mechanism of Rv2837c from Mycobacterium tuberculosis as a c-di-NMP Phosphodiesterase. He Q; Wang F; Liu S; Zhu D; Cong H; Gao F; Li B; Wang H; Lin Z; Liao J; Gu L J Biol Chem; 2016 Feb; 291(7):3668-81. PubMed ID: 26668313 [TBL] [Abstract][Full Text] [Related]
9. Implications of PDE4 structure on inhibitor selectivity across PDE families. Ke H Int J Impot Res; 2004 Jun; 16 Suppl 1():S24-7. PubMed ID: 15224132 [TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of a new human type 9 cGMP-specific phosphodiesterase splice variant (PDE9A5). Differential tissue distribution and subcellular localization of PDE9A variants. Wang P; Wu P; Egan RW; Billah MM Gene; 2003 Sep; 314():15-27. PubMed ID: 14527714 [TBL] [Abstract][Full Text] [Related]